Janus kinase (JAK) inhibitors look to be a good treatment option for the newly recognized, rare autoimmune disease known as SOCS1 insufficiency, researchers found. Which was not exactly a surprise.

Research in horses may eventually lead to a treatment for people who develop blindness as a result of the autoimmune disease recurrent uveitis, according to a study recently published in the Frontiers ...